课题基金 / 基金详情

项目摘要

项目成果

KENNETH D LAXER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this project is to determine the ability of 1H MRI/MRS at 4T to localize the epileptogenic focus in partial epilepsy and to predict the outcome of seizure surgery. This application proposes a continuing effort to improve the outcome of seizure surgery by better presurgical localization of intractable partial epilepsy using state of the art neuroimaging techniques. Specifically, we will determine the predictive 'Value added" of MRI (structural, arterial spin perfusion, and diffusion tensor imaging) and MRS (single voxel and 3D) imaging to the diagnostic evaluation of refractory epilepsy using a 4 Tesla scanner that will be optimized for investigation of neurodegenerative disease. This project will study patients with non-lesional, unifocal, medically refractory, localization related epilepsy. These techniques will be directed at two groups of patients with intractable epilepsy who are being evaluated for seizure surgery (numbers for 5 years): 1) patients with medial temporal lobe epilepsy with and without MRI evidence of mesial temporal sclerosis (n=80), 2) patients with non-lesional neocortical epilepsy (may include cortical malformations) (n=80). Post-operative surgical outcome will be analyzed in relation to the pre-operative neuroimaging findings. Hypotheses: 1) for patients with medically refractory complex partial seizures arising from either the medial temporal lobe or from neocortical regions, structural, perfusion, diffusion and MRS imaging at 4T will be a more sensitive measure of seizure lateralization/localization than conventional MRI performed at 1.5T; 2) for these two patient groups, MRI and MRS measures at 4T that are concordant with the lateralization by video/EEG telemetry will have significantly better post surgical outcomes than patients without concordance. All studies will be performed in a systematic, prospective, blinded, and controlled manner to predict the patients that respond best to seizure surgery. The significance of these studies is that the use of newly developed MRI and MRS techniques at high field strength will lead to improved epilepsy surgery outcomes and will reduce unnecessary surgery in patients with intractable epilepsy.
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
Multisection proton MR spectroscopy for mesial temporal lobe epilepsy.
多截面质子磁共振波谱治疗内侧颞叶癫痫。
DOI: --
发表时间: 2002
期刊: AJNR. American journal of neuroradiology
影响因子: --
作者: [Capizzano,ArístidesA, Vermathen,Peter, Laxer,KennethD, Matson,GeraldB, Maudsley,AndrewA, Soher,BrianJ, Schuff,NorbertW, Weiner,MichaelW]
通讯作者: Weiner,MichaelW
A two-level multimodality imaging Bayesian network approach for classification of partial epilepsy: preliminary data.
用于部分性癫痫分类的两级多模态成像贝叶斯网络方法:初步数据。
DOI: 10.1016/j.neuroimage.2013.01.014
发表时间: 2013
期刊: NeuroImage
影响因子: 5.7
作者: [Mueller,SusanneG, Young,Karl, Hartig,Miriam, Barakos,Jerome, Garcia,Paul, Laxer,KennethD]
通讯作者: Laxer,KennethD
DOI: 10.1016/j.pscychresns.2014.09.002
发表时间: 2014-12-30
期刊: Psychiatry research
影响因子: 11.3
作者: [Lindqvist D, Mueller S, Mellon SH, Su Y, Epel ES, Reus VI, Rosser R, Mahan L, Mackin RS, Yang TT, Wolkowitz OM]
通讯作者: Wolkowitz OM
DOI: 10.1111/j.1528-1167.2009.02413.x
发表时间: 2010-08
期刊: Epilepsia
影响因子: 5.6
作者: [Mueller SG, Laxer KD, Barakos J, Cheong I, Finlay D, Garcia P, Cardenas-Nicolson V, Weiner MW]
通讯作者: Weiner MW
19
    LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
    LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
    LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
    PLACEBO CONTROLLED STUDY TO EVALUATE GANAXOLONE IN COMPLEX PARTIAL SEIZURES
    国内基金
    海外基金
    Handbook of the Mathematics of the Arts and Sciences的中文翻译
    • 批准号:
      12226504
    • 项目类别:
      数学天元基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2022
    • 负责人:
      黄朝凌
    • 依托单位:
    ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
    • 批准号:
      --
    • 项目类别:
      --
    • 资助金额:
      35万元
    • 批准年份:
      2020
    • 负责人:
      陈加祥
    • 依托单位:
    ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
    • 批准号:
      82060278
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      35.0万元
    • 批准年份:
      2020
    • 负责人:
      陈加祥
    • 依托单位:
    促进肿瘤凋亡的融合蛋白CPP-TRAIL-ARTS C27的制备及机制研究
    • 批准号:
      81372444
    • 项目类别:
      面上项目
    • 资助金额:
      70.0万元
    • 批准年份:
      2013
    • 负责人:
      易成
    • 依托单位: